how does glp-1 affect the brain Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine GLP-1 receptor agonism: a transformative

Bonhoure, N., Byrnes, A., Moir, R

GLP-1 medications such as semaglutide work primarily by suppressing appetite

Rapamycin, an mTOR inhibitor, similarly promotes autophagy, attenuates pathological remodeling and is now in phase II clinical trials for HFpEF (Tables 1 and 2)

& Schlegel, V

Tirzepatide and incretin-based therapies for diabetes and obesity

Evidence from metabolic organs suggests a potential biphasic behavior, early contact enrichment and heightened flux followed by late-stage decoupling (Theurey and Rieusset, 2017), raising the possibility that GLP-1R agonists may exert qualitatively different effects depending on whether the limiting factor is excessive Ca 2+ transfer versus structural collapse of tethering and scaffolding networks